Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease | Zendy

John W. Eikelboom | Zendy; Stuart J. Connolly | Zendy; Jackie Bosch | Zendy; Gilles R. Dagenais | Zendy; Robert G. Hart | Zendy; Olga Shestakovska | Zendy; Rafael Díaz | Zendy; Marco Alings | Zendy; Eva Lonn | Zendy; Sonia S. Anand | Zendy; Petr Widimský | Zendy; Masatsugu Hori | Zendy; Álvaro Avezum | Zendy; Leopoldo Soares Piegas | Zendy; Kelley R. Branch | Zendy; Jeffrey L. Probstfield | Zendy; Deepak L. Bhatt | Zendy; Jun Zhu | Zendy; Yan Liang | Zendy; Aldo P. Maggioni | Zendy; Patricio LópezJaramillo | Zendy; Martin O’Donnell | Zendy; Ajay K. Kakkar | Zendy; Keith A.A. Fox | Zendy; Alexander Parkhomenko | Zendy; Georg Ertl | Zendy; Stefan Störk | Zendy; Matyàs Keltai | Zendy; Lars Rydén | Zendy; Nana Pogosova | Zendy; Antonio L Dans | Zendy; Fernando Laņas | Zendy; Patrick Commerford | Zendy; Christian TorpPedersen | Zendy; Tomasz J. Guzik | Zendy; Peter Verhamme | Zendy; Dragoş Vinereanu | Zendy; JaeHyung Kim | Zendy; Andrew M. Tonkin | Zendy; Basil S. Lewis | Zendy; Camilo Félix | Zendy; Khalid Yusoff | Zendy; Philippe Gabríel Steg | Zendy; Kaj Metsärinne | Zendy; Nancy Cook Bruns | Zendy; Frank Misselwitz | Zendy; Edmond Chen | Zendy; Darryl P. Leong | Zendy; Salim Yusuf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

Author(s) -

John W. Eikelboom,

Stuart J. Connolly,

Jackie Bosch,

Gilles R. Dagenais,

Robert G. Hart,

Olga Shestakovska,

Rafael Díaz,

Marco Alings,

Eva Lonn,

Sonia S. Anand,

Petr Widimský,

Masatsugu Hori,

Álvaro Avezum,

Leopoldo Soares Piegas,

Kelley R. Branch,

Jeffrey L. Probstfield,

Deepak L. Bhatt,

Jun Zhu,

Yan Liang,

Aldo P. Maggioni,

Patricio LópezJaramillo,

Martin O’Donnell,

Ajay K. Kakkar,

Keith A.A. Fox,

Alexander Parkhomenko,

Georg Ertl,

Stefan Störk,

Matyàs Keltai,

Lars Rydén,

Nana Pogosova,

Antonio L Dans,

Fernando Laņas,

Patrick Commerford,

Christian TorpPedersen,

Tomasz J. Guzik,

Peter Verhamme,

Dragoş Vinereanu,

JaeHyung Kim,

Andrew M. Tonkin,

Basil S. Lewis,

Camilo Félix,

Khalid Yusoff,

Philippe Gabríel Steg,

Kaj Metsärinne,

Nancy Cook Bruns,

Frank Misselwitz,

Edmond Chen,

Darryl P. Leong,

Salim Yusuf

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1709118

Subject(s) - rivaroxaban , medicine , aspirin , disease , cardiology , intensive care medicine , atrial fibrillation , warfarin

We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore